Transitional Drugs 5

A Contract Award Notice
by NHS WALES SHARED SERVICES PARTNERSHIP-PROCUREMENT SERVICES (HOSTED BY VELINDRE UNIVERSITY NHS TRUST)

Source
Find a Tender
Type
Contract ()
Duration
not specified
Value
£6M
Sector
MISCELLANEOUS
Published
08 Dec 2025
Delivery
not specified
Deadline
n/a

Related Terms

Location

Geochart for 1 buyers and 3 suppliers

Description

The provision of drugs that have recently lost exclusivity, namely Aflibercept; Dapagliflozin; Golimumab

Award Detail

1 Mercury Pharmaceuticals (London)
  • Transitional Drugs 5
  • Reference: 1
  • Value: £5,577,339 [share]
  • Awarded to group of suppliers.
2 Teva (Castleford)
  • Transitional Drugs 5
  • Reference: 1
  • Value: £5,577,339 [share]
  • Awarded to group of suppliers.
3 Janssen (High Wycombe)
  • Transitional Drugs 5
  • Reference: 1
  • Value: £5,577,339 [share]
  • Awarded to group of suppliers.

CPV Codes

  • None found

Indicators

Other Information

** PREVIEW NOTICE, please check Find a Tender for full details. **

Reference

  • ocds-h6vhtk-05a8e6
  • FTS 080771-2025

Domains